Results

Total Results: 1,185 records

Showing results for "author year description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - primary outcomes 3 Description of secondary outcome Analysis Description of the pre-specified … or the year of study completion. … Description of the Identified Studies Question 2. … Description of the Identified Studies Question 2. … Description of the Identified Studies Question 2.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
    July 27, 2023 - Intervention RQs 1-4: Not applicable (description of harms associated with anticoagulant use in the … Description of Included Studies To efficiently describe eligible studies, the full text of each potentially … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, study design, number of study part... … To describe eligible systematic reviews, a single team member will prepare a summary including the author
  3. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/management-vestibular-schwannomas
    June 11, 2021 - Home » Get Involved » Nominated Topics » Topic Suggestion Description … Topic Suggestion Description Date submitted: June 11, 2021 Management of Vestibular
  4. effectivehealthcare.ahrq.gov/products/diabetes-glucose-control/research
    August 04, 2010 - Author Affiliations Jodi B. Segal, M.D., M.P.H. a Sydney M. Dy, M.D. b E. … Results   Description of the Cohort We received data on 1,234,540 individuals meeting the broad … Description of Individuals Using Exenatide by Treatment Period In Table 1 is a description of the … Description of individuals with diabetes mellitus by date of first exenatide use Covariates First … Description of individuals with diabetes mellitus stratified by injectable medication use Covariates
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Was there a clear description of the techniques used to identify the events? 5. … Was the description of the population adequate? 2. … Trials of rofecoxib vs NSAIDs Author year Aspirin permitted? … Trials of etoricoxib and lumiracoxib (Safety only) Author Year Patient masked? … Topical NSAIDs trials External Validity Author Year Patient masked?
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
    July 01, 2010 - ...........................................................................................7 Author … Results Description of the Cohort We received data on 1,234,540 individuals meeting the broad criteria … Description of Individuals Using Exenatide by Treatment Period In Table 1 is a description of the patients … Description of individuals with diabetes mellitus stratified by injectable medication use Covariates … Description of individuals with diabetes mellitus stratified by injectable medication use (continued)
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-models-care-draft-report-appendixes.pdf
    August 18, 2023 - , Year Model Description/name Model Location and Organization Country Setting Population Served … , Year Model Description/name Model Location and Organization Country Setting Population Served … , Year Model Description/name Model Location and Organization Country Setting Population Served … , Year Model Description/name Model Location and Organization Country Setting Population Served … , Year Model Description/name Model Location and Organization Country Setting Population Served
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
    January 15, 2013 - Evidence Table Study Description Intervention Inclusion/Exclusion Criteria/ Population Baseline … on a protein-restricted diet and the rest were on BH4. 97.7% of the early diagnosed Study Description … Analysis of lifetime Phe data showed that Phe levels at ages 4, 5, and 6 accounted for Study Description … within therapeutic targets and a decrease in the values above target…, and decreased the Study Description … No studies identified Study Description Intervention Inclusion/Exclusion Criteria/ Population
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
    July 01, 2023 - Timing Original studies published from 2019 onwards, the year of the search done for the MHS III report … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
    October 29, 2021 - high-utilizers-health-care/research Published Online: October 29, 2021 2 Summary of Peer Reviewer Comments and Author … Changes included improving the description of the inclusion/exclusion criteria in methods; more clearly … We expanded our description of the realist review literature rigor assessment to better explain how … high-utilizers-health-care/research Published Online: October 29, 2021 5 Public Comments and Author … stakeholder interpretation of LCA and k-means outputs, and demonstrates significant differences in 1-year
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/economic-evaluation-tools_research.pdf
    October 01, 2012 - Did the authors provide a detailed description of the alternatives? a. … Source and description of cost valuation 17. … Description of comparator programs 6. Boundaries of the analysis 7. Time horizon 8. … Description of model used 12. Modeling assumptions 13. Diagram of event pathway 14. … Did the author(s) explicitly discuss direction and magnitude of potential biases? 15.
  12. effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
    May 26, 2016 - Comment Response Peer Reviewer #1 Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description of the findings to the beginning of the result … We have included a description of and a citation for the DECIDE study in the “Future Areas for Research … Peer Reviewer #2 Background The Background was thorough in its description of the clinical problem … Peer Reviewer #4 Methods “Systematic review” may not be the most appropriate description of this
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
    July 01, 2023 - • No outcome of interest Timing Original studies published from 2011 onwards, the year of the … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
    September 01, 2020 - This report is made available to the public under the terms of a licensing agreement between the author … Implementation Strategies No description No description No description No description No description … No description No description No description 28. … Organizational History of Change No description No description No description No description No description … Fidelity No description No description No description No description No description No description
  15. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-insurance-prior-authorizations.pdf
    December 03, 2020 - 2017. doi: https://www.cdc.gov/nchs/data/nsltcp/2016_NSLTCP_RCC_Weighted_Estimates.pdf. 4 Author … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
    August 04, 2023 - In the United States, more than 2.8 million antimicrobial-resistant infections occur each year and … Usual practice or other type of PSP • No concurrent or historical comparison group • No clear descriptionDescription of Included Studies To efficiently describe eligible studies, the full text of each potentially … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … To describe eligible systematic reviews, a single team member will prepare a summary including the author
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
    January 01, 2020 - Patient populations (continued) Author, Year Country, Study Design Inclusion Criteria Exclusion … Patient populations (continued) Author, Year Country, Study Design Inclusion Criteria Exclusion … Patient populations (continued) Author, Year Country, Study Design Inclusion Criteria Exclusion … Patient populations (continued) Author, Year Country, Study Design Inclusion Criteria Exclusion … Vibration interventions II Author, Year Type of Footwear Worn on Platform Support Device
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - However, a description of meta-analysis goes beyond this report. … The description of industry funding has been removed. … The description of industry funding has been removed. … (Lovell, Reiff, Jones, et al., 2006) or 8-year (Lovell, Reiff, Ilowite, et al., 2008 follow- up. … However, the description of methotrexate has been expanded.
  19. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-the-disabled-and-elderly-with-multiple-comorbidities-what-is-the-comparative-effectiveness-of-physician-housecalls-on-outcomes-and-total-cost
    November 21, 2012 - Home » Get Involved » Nominated Topics » Topic Suggestion Description … Topic Suggestion Description Date submitted: November 21, 2012 Download Topic Suggestion … of PPACA) gives CMS the authority to expand the gainsharing bonus program nationwide after the first year … Nominator Information Other Information About You: (optional) Please choose a description that … of PPACA) gives CMS the authority to expand the gainsharing bonus program nationwide after the first year
  20. Appendixes A-E (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-draft-appendixes.pdf
    January 01, 2024 - C-5 Author, year Goal Review Limitations* Summarized Evidence Main Findings Vaartio-Rajalin, … C-8 Author, year Goal Review Limitations* Summarized Evidence Main Findings Jutkowitz, 201616 … C-10 Author, year Goal Review Limitations* Summarized Evidence Main Findings Oeseburg, 200925 … Characteristics of included primary studies: Randomized controlled trials Author, Year; Length of … Usual Care: OR: 1.37 (95% CI: 0.72, 6.16) D-6 Author, Year; Length of Followup Population

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: